Trial: 201904214

IMPACT: Immunotherapy in Patients with Metastatic Cancers and CDK12 Mutations

Phase

II (Cancer Control)

Principal Investigator

Reimers, Melissa

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov